Ampio Pharmaceuticals Earns Sell Rating from Analysts at StockNews.com
AMPEDelisted Stock | USD 0.24 0.01 4.35% |
About 55% of Ampio Pharm's shareholders are presently thinking to get in. The analysis of overall sentiment of trading Ampio Pharm pink sheet suggests that some investors are interested at this time. The current market sentiment, together with Ampio Pharm's historical and current headlines, can help investors time the market. In addition, many technical investors use Ampio Pharm stock news signals to limit their universe of possible portfolio assets.
Ampio Pharm pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Ampio daily returns and investor perception about the current price of Ampio Pharm as well as its diversification or hedging effects on your existing portfolios.
Ampio |
StockNews.com began coverage on shares of Ampio Pharmaceuticals in a research note issued to investors on Wednesday. The firm issued a sell rating on the stock. Ampio Pharmaceuticals Stock Down 6.3 percent Shares of AMPE stock opened at 1.79 on Wednesday. The stock has a market cap of 1.49 million, a
Read at thelincolnianonline.com
Ampio Pharm Fundamental Analysis
We analyze Ampio Pharm's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ampio Pharm using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ampio Pharm based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Number Of Employees
Number Of Employees Comparative Analysis
Ampio Pharm is currently under evaluation in number of employees category among its peers. Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
Ampio Pharm Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Ampio Pharm pink sheet to make a market-neutral strategy. Peer analysis of Ampio Pharm could also be used in its relative valuation, which is a method of valuing Ampio Pharm by comparing valuation metrics with similar companies.
Peers
Ampio Pharm Related Equities
CADL | Candel Therapeutics | 4.55 | ||||
SYBX | Synlogic | 4.17 | ||||
ANTX | AN2 Therapeutics | 3.70 | ||||
ZVSA | ZyVersa Therapeutics | 4.07 | ||||
PULM | Pulmatrix | 4.31 | ||||
ACIU | AC Immune | 4.44 | ||||
REVB | Revelation Biosciences | 4.92 | ||||
RNAZ | Transcode Therapeutics | 4.99 | ||||
QNRX | Quoin Pharmaceuticals | 6.06 | ||||
PHIO | Phio Pharmaceuticals | 6.63 | ||||
GLUE | Monte Rosa | 8.27 | ||||
AKTX | Akari Therapeutics | 9.22 | ||||
ZURA | Zura Bio | 9.96 | ||||
SONN | Sonnet Biotherapeutics | 12.92 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Consideration for investing in Ampio Pink Sheet
If you are still planning to invest in Ampio Pharm check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Ampio Pharm's history and understand the potential risks before investing.
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Global Correlations Find global opportunities by holding instruments from different markets |